Stock Events

Adaptimmune Therapeutics (ADAP) Q1 2023 Earnings

12MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.28
-0.19
-0.09
0

Details

Expected EPS
-0.14
Actual EPS
0
Surprise EPS
0.14
Surprise Percent
+100%

Description

Adaptimmune Therapeutics (ADAP) will report earnings of for Q1 2023 on May 12, 2023.

0 Comments

Share your thoughts